Photobiomodulation for Global Cerebral Ischemia

Targeting Mitochondrial Dynamics and Functions

Ruimin Wang, Yan Dong, Yujiao Lu, Wenli Zhang, Darrell W Brann, Quanguang Zhang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hypothermia is currently the only approved therapy for global cerebral ischemia (GCI) after cardiac arrest; however, it unfortunately has multiple adverse effects. As a noninvasive procedure, photobiomodulation (PBM) therapy has emerged as a potential novel treatment for brain injury. PBM involves the use of low-level laser light therapy to influence cell behavior. In this study, we evaluated the therapeutic effects of PBM treatment with an 808-nm diode laser initiated 6 h after GCI. It was noted that PBM dose-dependently protected against GCI-induced neuronal death in the vulnerable hippocampal CA1 subregion. Functional assessments demonstrated that PBM markedly preserved both short-term (a week) and long-term (6 months) spatial learning and memory function following GCI. Further mechanistic studies revealed that PBM post-treatment (a) preserved healthy mitochondrial dynamics and suppressed substantial mitochondrial fragmentation of CA1 neurons, by reducing the detrimental Drp1 GTPase activity and its interactions with adaptor proteins Mff and Fis1 and by balancing mitochondrial targeting fission and fusion protein levels; (b) reduced mitochondrial oxidative damage and excessive mitophagy and restored mitochondrial overall health status and preserved mitochondrial function; and (c) suppressed mitochondria-dependent apoptosome formation/caspase-3/9 apoptosis-processing activities. Additionally, we validated, in an in vitro ischemia model, that cytochrome c oxidase served as a key PBM target for mitochondrial function preservation and neuroprotection. Our findings suggest that PBM serves as a promising therapeutic strategy for the functional recovery after GCI, with mechanisms involving PBM’s preservation on mitochondrial dynamics and functions and the inhibition of delayed apoptotic neuronal death in GCI.

Original languageEnglish (US)
Pages (from-to)1852-1869
Number of pages18
JournalMolecular Neurobiology
Volume56
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Mitochondrial Dynamics
Brain Ischemia
Apoptosomes
Mitochondrial Degradation
Therapeutics
Semiconductor Lasers
Caspase 9
GTP Phosphohydrolases
Therapeutic Uses
Electron Transport Complex IV
Heart Arrest
Hypothermia
Caspase 3
Brain Injuries
Health Status
Mitochondria
Proteins
Ischemia
Apoptosis
Neurons

Keywords

  • Apoptosis
  • Cognition
  • Global cerebral ischemia
  • Mitochondrial dysfunction
  • Photobiomodulation therapy

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Photobiomodulation for Global Cerebral Ischemia : Targeting Mitochondrial Dynamics and Functions. / Wang, Ruimin; Dong, Yan; Lu, Yujiao; Zhang, Wenli; Brann, Darrell W; Zhang, Quanguang.

In: Molecular Neurobiology, Vol. 56, No. 3, 01.03.2019, p. 1852-1869.

Research output: Contribution to journalArticle

@article{1e680d02179e4cc289b6b8d3a38bde8c,
title = "Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions",
abstract = "Hypothermia is currently the only approved therapy for global cerebral ischemia (GCI) after cardiac arrest; however, it unfortunately has multiple adverse effects. As a noninvasive procedure, photobiomodulation (PBM) therapy has emerged as a potential novel treatment for brain injury. PBM involves the use of low-level laser light therapy to influence cell behavior. In this study, we evaluated the therapeutic effects of PBM treatment with an 808-nm diode laser initiated 6 h after GCI. It was noted that PBM dose-dependently protected against GCI-induced neuronal death in the vulnerable hippocampal CA1 subregion. Functional assessments demonstrated that PBM markedly preserved both short-term (a week) and long-term (6 months) spatial learning and memory function following GCI. Further mechanistic studies revealed that PBM post-treatment (a) preserved healthy mitochondrial dynamics and suppressed substantial mitochondrial fragmentation of CA1 neurons, by reducing the detrimental Drp1 GTPase activity and its interactions with adaptor proteins Mff and Fis1 and by balancing mitochondrial targeting fission and fusion protein levels; (b) reduced mitochondrial oxidative damage and excessive mitophagy and restored mitochondrial overall health status and preserved mitochondrial function; and (c) suppressed mitochondria-dependent apoptosome formation/caspase-3/9 apoptosis-processing activities. Additionally, we validated, in an in vitro ischemia model, that cytochrome c oxidase served as a key PBM target for mitochondrial function preservation and neuroprotection. Our findings suggest that PBM serves as a promising therapeutic strategy for the functional recovery after GCI, with mechanisms involving PBM’s preservation on mitochondrial dynamics and functions and the inhibition of delayed apoptotic neuronal death in GCI.",
keywords = "Apoptosis, Cognition, Global cerebral ischemia, Mitochondrial dysfunction, Photobiomodulation therapy",
author = "Ruimin Wang and Yan Dong and Yujiao Lu and Wenli Zhang and Brann, {Darrell W} and Quanguang Zhang",
year = "2019",
month = "3",
day = "1",
doi = "10.1007/s12035-018-1191-9",
language = "English (US)",
volume = "56",
pages = "1852--1869",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Photobiomodulation for Global Cerebral Ischemia

T2 - Targeting Mitochondrial Dynamics and Functions

AU - Wang, Ruimin

AU - Dong, Yan

AU - Lu, Yujiao

AU - Zhang, Wenli

AU - Brann, Darrell W

AU - Zhang, Quanguang

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Hypothermia is currently the only approved therapy for global cerebral ischemia (GCI) after cardiac arrest; however, it unfortunately has multiple adverse effects. As a noninvasive procedure, photobiomodulation (PBM) therapy has emerged as a potential novel treatment for brain injury. PBM involves the use of low-level laser light therapy to influence cell behavior. In this study, we evaluated the therapeutic effects of PBM treatment with an 808-nm diode laser initiated 6 h after GCI. It was noted that PBM dose-dependently protected against GCI-induced neuronal death in the vulnerable hippocampal CA1 subregion. Functional assessments demonstrated that PBM markedly preserved both short-term (a week) and long-term (6 months) spatial learning and memory function following GCI. Further mechanistic studies revealed that PBM post-treatment (a) preserved healthy mitochondrial dynamics and suppressed substantial mitochondrial fragmentation of CA1 neurons, by reducing the detrimental Drp1 GTPase activity and its interactions with adaptor proteins Mff and Fis1 and by balancing mitochondrial targeting fission and fusion protein levels; (b) reduced mitochondrial oxidative damage and excessive mitophagy and restored mitochondrial overall health status and preserved mitochondrial function; and (c) suppressed mitochondria-dependent apoptosome formation/caspase-3/9 apoptosis-processing activities. Additionally, we validated, in an in vitro ischemia model, that cytochrome c oxidase served as a key PBM target for mitochondrial function preservation and neuroprotection. Our findings suggest that PBM serves as a promising therapeutic strategy for the functional recovery after GCI, with mechanisms involving PBM’s preservation on mitochondrial dynamics and functions and the inhibition of delayed apoptotic neuronal death in GCI.

AB - Hypothermia is currently the only approved therapy for global cerebral ischemia (GCI) after cardiac arrest; however, it unfortunately has multiple adverse effects. As a noninvasive procedure, photobiomodulation (PBM) therapy has emerged as a potential novel treatment for brain injury. PBM involves the use of low-level laser light therapy to influence cell behavior. In this study, we evaluated the therapeutic effects of PBM treatment with an 808-nm diode laser initiated 6 h after GCI. It was noted that PBM dose-dependently protected against GCI-induced neuronal death in the vulnerable hippocampal CA1 subregion. Functional assessments demonstrated that PBM markedly preserved both short-term (a week) and long-term (6 months) spatial learning and memory function following GCI. Further mechanistic studies revealed that PBM post-treatment (a) preserved healthy mitochondrial dynamics and suppressed substantial mitochondrial fragmentation of CA1 neurons, by reducing the detrimental Drp1 GTPase activity and its interactions with adaptor proteins Mff and Fis1 and by balancing mitochondrial targeting fission and fusion protein levels; (b) reduced mitochondrial oxidative damage and excessive mitophagy and restored mitochondrial overall health status and preserved mitochondrial function; and (c) suppressed mitochondria-dependent apoptosome formation/caspase-3/9 apoptosis-processing activities. Additionally, we validated, in an in vitro ischemia model, that cytochrome c oxidase served as a key PBM target for mitochondrial function preservation and neuroprotection. Our findings suggest that PBM serves as a promising therapeutic strategy for the functional recovery after GCI, with mechanisms involving PBM’s preservation on mitochondrial dynamics and functions and the inhibition of delayed apoptotic neuronal death in GCI.

KW - Apoptosis

KW - Cognition

KW - Global cerebral ischemia

KW - Mitochondrial dysfunction

KW - Photobiomodulation therapy

UR - http://www.scopus.com/inward/record.url?scp=85049093394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049093394&partnerID=8YFLogxK

U2 - 10.1007/s12035-018-1191-9

DO - 10.1007/s12035-018-1191-9

M3 - Article

VL - 56

SP - 1852

EP - 1869

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 3

ER -